[DISCLOSURE]
Ilyang Pharmaceutical (007570) announced on June 27 that it has signed a US$22 million (excluding supplied value of end products) contract with Columbia’s Biopas to supply technology and finished products for leukemia treatment, for sales in Columbia and eight other countries.
